Transform Wealth LLC Has $6.73 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Transform Wealth LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 54.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,508 shares of the healthcare conglomerate’s stock after selling 13,779 shares during the quarter. Transform Wealth LLC’s holdings in UnitedHealth Group were worth $6,729,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Swedbank AB acquired a new stake in UnitedHealth Group during the first quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares during the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at $480,903,000. Dimensional Fund Advisors LP boosted its position in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. increased its position in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after acquiring an additional 821,050 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently commented on UNH. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday. Barclays raised their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday. Morgan Stanley reduced their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $615.16.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $571.30 on Thursday. The company has a market capitalization of $527.55 billion, a P/E ratio of 37.88, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company’s 50-day moving average is $584.21 and its 200 day moving average is $532.84.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 EPS. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.